• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.一个大的U3缺失导致非整合型慢病毒载体在体内的表达增加。
Mol Ther. 2008 Dec;16(12):1968-76. doi: 10.1038/mt.2008.199. Epub 2008 Sep 16.
2
Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.显著减少由缺失 PPT 的非整合慢病毒载体介导的非法整合。
Mol Ther. 2011 Mar;19(3):547-56. doi: 10.1038/mt.2010.277. Epub 2010 Dec 14.
3
Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.由早期HIV-1衍生慢病毒载体中的U3区域介导的启动子干扰可通过细胞类型和物种特异性方式影响转基因表达的检测。
Hum Gene Ther. 2003 Aug 10;14(12):1127-37. doi: 10.1089/104303403322167975.
4
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
5
Integrase defective, nonintegrating lentiviral vectors.整合酶缺陷型、非整合型慢病毒载体。
Methods Mol Biol. 2010;614:101-10. doi: 10.1007/978-1-60761-533-0_6.
6
Use of nonintegrating lentiviral vectors for gene therapy.非整合型慢病毒载体在基因治疗中的应用。
Hum Gene Ther. 2007 Jun;18(6):483-9. doi: 10.1089/hum.2007.013.
7
Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.来自有丝分裂稳定的整合缺陷型慢病毒载体的长期附加型转基因表达。
Hum Gene Ther. 2014 May;25(5):428-42. doi: 10.1089/hum.2013.172. Epub 2014 Apr 10.
8
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.带有缺陷整合酶的慢病毒载体能够在体外和体内实现高效且持续的转基因表达。
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9. doi: 10.1073/pnas.0606197103. Epub 2006 Nov 9.
9
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.为 BSL-0 环境设计的超高效慢病毒载体可消除载体的转移。
Gene Ther. 2018 Oct;25(7):454-472. doi: 10.1038/s41434-018-0039-2. Epub 2018 Sep 6.
10
Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.非整合型慢病毒载体在载体-基因组加工及异常整合方面的差异。
Gene Ther. 2017 Jan;24(1):12-20. doi: 10.1038/gt.2016.69. Epub 2016 Sep 28.

引用本文的文献

1
Analysis of Hepatic Lentiviral Vector Transduction: Implications for Preclinical Studies and Clinical Gene Therapy Protocols.肝内慢病毒载体转导分析:对临床前研究和临床基因治疗方案的启示。
Viruses. 2025 Feb 17;17(2):276. doi: 10.3390/v17020276.
2
Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols.肝内慢病毒载体转导分析;对临床前研究和临床基因治疗方案的影响。
bioRxiv. 2024 Aug 31:2024.08.20.608805. doi: 10.1101/2024.08.20.608805.
3
Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing.用于CRISPR-Cas9基因编辑的工程单周期兆电子伏特载体。
Mol Ther Methods Clin Dev. 2024 Jun 24;32(3):101290. doi: 10.1016/j.omtm.2024.101290. eCollection 2024 Sep 12.
4
The potential of gene delivery for the treatment of traumatic brain injury.基因传递在创伤性脑损伤治疗中的潜力。
J Neuroinflammation. 2024 Jul 28;21(1):183. doi: 10.1186/s12974-024-03156-x.
5
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy.CRISPR/Cas9基因编辑技术在神经退行性疾病治疗中的进展:通往治疗的正确道路
Biomedicines. 2023 Dec 17;11(12):3333. doi: 10.3390/biomedicines11123333.
6
HIV Preintegration Transcription and Host Antagonism.HIV 前整合转录与宿主拮抗。
Curr HIV Res. 2023;21(3):160-171. doi: 10.2174/1570162X21666230621122637.
7
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.疾病状态下基因表达的治疗性调控:下一代表观遗传药物开发的治疗策略与方法
Front Bioeng Biotechnol. 2022 Oct 17;10:1035543. doi: 10.3389/fbioe.2022.1035543. eCollection 2022.
8
Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial.自体皮肤源性神经前体细胞治疗在概念验证兽医试验中逆转犬类阿尔茨海默病样综合征。
Stem Cell Res Ther. 2022 Jun 17;13(1):261. doi: 10.1186/s13287-022-02933-w.
9
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through.临床应用中的非整合型慢病毒载体:概述
Biomedicines. 2022 Jan 5;10(1):107. doi: 10.3390/biomedicines10010107.
10
Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization.基于猿猴免疫缺陷病毒的整合酶缺陷型慢病毒载体用于免疫接种的安全性和效率改进
Mol Ther Methods Clin Dev. 2021 Oct 1;23:263-275. doi: 10.1016/j.omtm.2021.09.011. eCollection 2021 Dec 10.

本文引用的文献

1
Stable gene transfer to muscle using non-integrating lentiviral vectors.使用非整合型慢病毒载体将基因稳定转移至肌肉。
Mol Ther. 2007 Nov;15(11):1947-54. doi: 10.1038/sj.mt.6300281. Epub 2007 Aug 14.
2
What are the consequences of the fourth case?第四个案例的后果是什么?
Mol Ther. 2007 Aug;15(8):1401-2. doi: 10.1038/sj.mt.6300263.
3
Successful immunization with a single injection of non-integrating lentiviral vector.单次注射非整合型慢病毒载体实现成功免疫。
Mol Ther. 2007 Sep;15(9):1716-23. doi: 10.1038/sj.mt.6300241. Epub 2007 Jun 26.
4
In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance.体内给予慢病毒载体可引发I型干扰素反应,该反应会限制肝细胞基因转移并促进载体清除。
Blood. 2007 Apr 1;109(7):2797-805. doi: 10.1182/blood-2006-10-049312.
5
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.带有缺陷整合酶的慢病毒载体能够在体外和体内实现高效且持续的转基因表达。
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9. doi: 10.1073/pnas.0606197103. Epub 2006 Nov 9.
6
Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo.腺相关病毒介导的甘丙肽表达及组成型分泌可在体内抑制边缘系统癫痫发作活动。
Mol Ther. 2006 Jul;14(1):63-8. doi: 10.1016/j.ymthe.2006.04.004. Epub 2006 May 30.
7
Transient gene expression by nonintegrating lentiviral vectors.非整合型慢病毒载体介导的瞬时基因表达
Mol Ther. 2006 Jun;13(6):1121-32. doi: 10.1016/j.ymthe.2006.01.008. Epub 2006 Mar 23.
8
A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.用于高滴度条件性自失活HIV-1载体的转导慢病毒包装细胞系。
Mol Ther. 2006 Aug;14(2):276-84. doi: 10.1016/j.ymthe.2005.12.015. Epub 2006 Mar 3.
9
Effective gene therapy with nonintegrating lentiviral vectors.使用非整合型慢病毒载体的有效基因治疗。
Nat Med. 2006 Mar;12(3):348-53. doi: 10.1038/nm1365. Epub 2006 Feb 19.
10
Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque.急性髓系白血病与恒河猴造血祖细胞中的逆转录病毒基因转移有关。
Blood. 2006 May 15;107(10):3865-7. doi: 10.1182/blood-2005-10-4108. Epub 2006 Jan 26.

一个大的U3缺失导致非整合型慢病毒载体在体内的表达增加。

A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

作者信息

Bayer Matthew, Kantor Boris, Cockrell Adam, Ma Hong, Zeithaml Brian, Li Xiangping, McCown Thomas, Kafri Tal

机构信息

Gene Therapy Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.

出版信息

Mol Ther. 2008 Dec;16(12):1968-76. doi: 10.1038/mt.2008.199. Epub 2008 Sep 16.

DOI:10.1038/mt.2008.199
PMID:18797449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2587457/
Abstract

The feasibility of using nonintegrating lentiviral vectors has been demonstrated by recent studies showing their ability to maintain transgene expression both in vitro and in vivo. Furthermore, human immunodeficiency virus-1 (HIV-1) vectors packaged with a mutated integrase were able to correct retinal disease in a mouse model. Interestingly, these results differ from earlier studies in which first-generation nonintegrating lentiviral vectors yielded insignificant levels of transduction. However, to date, a rigorous characterization of transgene expression from the currently used self-inactivating (SIN) nonintegrating lentiviral vectors has not been published. In this study, we characterize transgene expression from SIN nonintegrating lentiviral vectors. Overall, we found that nonintegrating vectors express transgenes at a significantly lower level than their integrating counterparts. Expression from nonintegrating vectors was improved upon introducing a longer deletion in the vector's U3 region. A unique shuttle-vector assay indicated that the relative abundance of the different episomal forms was not altered by the longer U3 deletion. Interestingly, the longer U3 deletion did not enhance expression in the corpus callosum of the rat brain, suggesting that the extent of silencing of episomal transcription is influenced by tissue-specific factors. Finally, and for the first time, episomal expression in the mouse liver was potent and sustained.

摘要

近期研究表明,非整合型慢病毒载体能够在体外和体内维持转基因表达,从而证明了其可行性。此外,包装有突变整合酶的人类免疫缺陷病毒1型(HIV-1)载体能够在小鼠模型中纠正视网膜疾病。有趣的是,这些结果与早期研究不同,早期研究中第一代非整合型慢病毒载体产生的转导水平微不足道。然而,迄今为止,尚未发表关于当前使用的自失活(SIN)非整合型慢病毒载体转基因表达的严格表征。在本研究中,我们对SIN非整合型慢病毒载体的转基因表达进行了表征。总体而言,我们发现非整合型载体表达转基因的水平明显低于整合型载体。在载体的U3区域引入更长的缺失后,非整合型载体的表达得到了改善。一种独特的穿梭载体检测表明,不同游离形式的相对丰度并未因更长的U3缺失而改变。有趣的是,更长的U3缺失并未增强大鼠脑胼胝体中的表达,这表明游离转录本沉默的程度受组织特异性因素影响。最后,首次发现小鼠肝脏中的游离表达强效且持久。